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Abstract Due to their transient nature, short-term ex-
posures can be dicult to detect and quantify using
conventional monitoring techniques. Biological moni-
toring may be capable of registering such exposures and
may also be used to estimate important toxicological
parameters. This paper investigates relationships be-
tween methanol concentrations in the blood, urine, and
breath of volunteers exposed to methanol vapor at
800 ppm for periods of 0.5, 1, 2, and 8 h. The results
indicate factors that must be considered for interpretat-
ion of the results of biological monitoring. For methanol,
concentrations are not proportional to the exposure
duration due to metabolic and other elimination pro-
cesses that occur concurrently with the exposure. First-
order clearance models can be used with blood, breath,
or urine concentrations to estimate exposures if the time
that has elapsed since the exposure and the model pa-
rameters are known. The 0.5 to 2-h periods of exposure
were used to estimate the half-life of methanol. Blood
data gave a half-life of 1:44 0:33 h. Comparable but
slightly more variable results were obtained using urine
data corrected for voiding time 1:55 0:67 h and
breath data corrected for mucous membrane desorption
1:40 0:38 h. Methanol concentrations in blood lag-
ged some 15±30 min behind the termination of exposure,
and concentrations in urine were further delayed.
Although breath sampling may be convenient, breath
concentrations re¯ect end-expired or alveolar air only if
subjects are in a methanol-free environment for 30 min
or more after the exposure. At earlier times, breath
concentrations included contributions from airway
desorption or diusion processes. As based on multi-
compartmental models, the desorption processes have
half-lives ranging between 0.6 and 5 min. Preliminary
estimates of the mucous membrane reservoir indicate
contributions of under 10% for a 0.5-h exposure and
smaller eects for longer periods of exposure.
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Introduction
Exposure to many compounds can be detected and po-
tentially quanti®ed using biological monitoring, i.e., the
measurement of a target compound or a metabolite in
breath, blood, urine, tissue, sweat, or saliva. Such
monitoring may be used to estimate doses resulting from
all exposure pathways, i.e., percutaneous absorption,
inhalation, and ingestion (Murthy and Halperin 1995),
and to advance knowledge related to the absorption,
distribution, and elimination of chemicals in the body
(Droz and Fiserova-Bergerova 1992). Many health
standards include criteria for both short- and long-term
exposure to airborne contaminants so as to re¯ect the
health signi®cance of the accumulated dose and the dose
rate, and biological monitoring may be used to evaluate
exposure to many contaminants. For example, the
threshold limit values include both 15-min (TLV-STEL)
and 8-h (TLV-TWA) air concentrations, which for
methanol are 250 and 200 ppm (310 and 260 mg/m3),
respectively, and the biological exposure index (BEI)
corresponding to the TLV-TWA is a methanol concen-
tration of 15 mg/l urine (ACGIH 1991).
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Transient exposures, which may cause high dose
rates, can be both dicult and costly to monitor
(Rappaport and Spear 1988). Many exposures in the
workplace and elsewhere can be considered transient, a
result of changes in factors such as chemical emissions,
ventilation, and worker movement. Moreover, short-
term high-concentration exposures may involve physio-
logical mechanisms somewhat or very dierent from
those of long-term exposures, with the possibility that
the biologically eective dose is not proportional to the
exposure time or concentration, in contrast to conven-
tional assumptions. For example, high levels of exposure
may saturate certain metabolic pathways (Kavet and
Nauss 1990; Droz and Fiserova-Bergerova 1992), and
the absorption of solvents in the mucous membrane of
the respiratory tract may aect the kinetics and uptake
of water-soluble vapors (Franzblau et al. 1995; Kumagai
and Matsunaga 1995). Biological monitoring may be
used to estimate the eective dose, partially or fully
defusing the biological issues related to uptake, redis-
tribution, and metabolism as well as the practical di-
culties of measuring concentrations with high time
resolution.
This paper presents results from an experimental
study of methanol exposure that examines responses
seen in blood, breath, and urine samples collected from
subjects exposed to methanol vapor at 800 ppm for pe-
riods ranging from 30 min to 8 h. The study investigates
clearance, the relationship between exposure duration,
dose, and uptake rate, and the eectiveness of breath,
blood, and urine measurements as BEIs. This is the ®rst
study to examine the relationship of blood, urine, and
breath samples to controlled inhalation exposures to
methanol of varying duration. A concentration above
the TLV is used that may be relevant to both occupa-
tional and nonoccupational settings where intermittent
and uncontrolled exposure can occur.
Methanol is a widely used solvent and potential
motor vehicle fuel, and workplace exposures have re-
sulted in cases of acute toxicity (Kavet and Nauss 1990).
A number of experimental and ®eld studies have ad-
dressed the relationship between inhalation exposures to
methanol and biological indicators, including methanol
and formate in end-shift urine and methanol in blood
(e.g., Leaf and Zatman 1952; Sedivec et al. 1981; Kawai
et al. 1991, 1992; Franzblau et al. 1992b, 1997; Yasugi
et al. 1992) as well as breath monitoring (Lee et al. 1992;
Franzblau et al. 1992a, 1995). Methanol readily passes
into and through the skin, and the role of the dermal
exposure pathway has been demonstrated in several re-
ports (Dutkiewicz et al. 1980; Franzblau et al. 1995;
Batterman et al. 1996a; Batterman and Franzblau 1997).
The pharmocokinetic models needed to interpret bio-
logical monitoring of methanol are largely generic, but
models speci®c to methanol have been formulated
(Horton et al. 1992; Perkins et al. 1995). The data de-
scribed herein have not previously been presented, al-
though many experimental details are shared in related
studies by the authors (e.g., Franzblau et al. 1995, 1997;




The exposure protocol consisted of separate sessions for each
subject, scheduled at least 1 week apart. Each of the four core
subjects stayed in the exposure chamber for 30, 60, and 120 min,
and each repeated the session a second time (and a third time in the
case of one subject in the 120-min exposure). Thus, the total short-
term sample consisted of 3 exposure durations ´ 4 subjects ´ re-
plicates +1 additional replicate  25 sessions. In addition, 15
sessions of 8-h duration and 12 sessions as controls were con-
ducted. The 8-h exposures included dierent (noncore) subjects,
some of whom also participated in the control exposures. Similar
procedures were followed in each session, including controls, al-
though the timing of collection of some samples varied slightly as
described below.
Exposures were conducted in a 47-m3 stainless-steel exposure
chamber containing a suspended ¯oor and ceiling, a restroom, and
an airlock entry. The chamber was maintained at 50% relative
humidity and 22 °C and was ventilated at 18 chamber volumes/h
with air ®ltered for particulate and gaseous contaminants. Meth-
anol vapor was introduced via a two-stage vapor generator and
metered into the ventilation air ¯ow using a mass ¯ow controller to
achieve the desired concentration of 800 ppm. A dedicated MIR-
AN 1-A (Foxboro Co., Foxboro, MA) infrared analyzer continu-
ously monitored chamber air in each session. Concentrations were
maintained within 1% of the target concentration.
Breath sampling and analysis
Two breath samples were collected at 10 and 15 min before
each short-term exposure session. Breath samples were collected at
0, 15, 30, and 45 min, as well as 1, 1.5, 2, 3, 4, 5, 6, 7, and 8 h after
departure from the exposure chamber in the 30-min duration and
control sessions. A similar schedule was followed for the longer-
exposure sessions, but to keep the sessions' length to 8 or 9 h, the
®nal sample and the last two samples were eliminated for 1- and 2-h
exposures, respectively. In the 8-h exposure, single breath samples
were collected prior to exposure, immediately upon departure from
the exposure chamber, and at 5, 10, and 15-min thereafter.
Breath samples were collected using a breath maneuver and
sampling system that captured alveolar air in 0.5 l aluminized
Mylar gas-sampling bags (Quintron Instrument Co., Milwaukee,
Wis.). The gas-sampling bags were analyzed for methanol and
carbon dioxide (CO2) using Fourier transform infrared (FTIR)
analysis within 1 day of sampling. CO2 measurements were taken
to ensure that breath samples represented alveolar air. After
warming of the sampling bag the sample was transferred to an
evacuated 5-m path-length gas cell of a Bomem MB-100a (Mon-
treal, Canada) FTIR spectrometer equipped with a mercury-cad-
mium-telluride (MCT) nitrogen-cooled detector. Cell pressure was
maintained at 500 mmHg to avoid sample condensation. IR spec-
tra were collected at 2 cm)1 resolution using 32 scans and were
®tted using an ordinary least-squares procedure and reference
spectra, e.g., 2% CO2 in N2 (Scotts Specialty Gases, Troy, Mich.)
and 50 and 1000 ppm methanol in N2. The limit of detection
(LOD) for methanol was 0.5 ppm, and the coecient of variation
(COV) was 2%.
Blood sampling and analysis
Blood samples were collected at 0, 15, and 30 min as well as 1, 2, 3,
4, 5, 6, and 7 h following exposure in the short-term and control
sessions and at 6 and 8 h into the 8-h duration session. The 7-h
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sample was omitted in the 2-h exposure session. Two samples were
also collected prior to exposure. Blood was drawn from the sub-
ject's arm into a ``gray top'' Vacutainer tube (containing potassium
oxalate and sodium ¯uoride), which was immediately refrigerated.
Methanol concentrations were determined for two replicates of
each blood sample using head-space gas chromatography and
¯ame ionization detection. For these measurements the LOD was
0.5 mg/l and COVs were 3±5%.
Urine sampling and analysis
All voided specimens were collected by subjects in standard hos-
pital-collection containers and were immediately measured for
volume and speci®c gravity by refractometry. Void specimens were
requested prior to the exposure and at the end of the session.
Otherwise, spontaneous voids were collected. Aliquots were stored
at 4 °C for later analyses of methanol using head-space gas chro-
matography. LODs recorded for methanol in urine were below
0.5 mg/l.
Study population
The core subjects consisted of four women aged 41±63 years who
participated in all short-term exposure sessions. The same four
women, plus eight others, participated in the control sessions. In
all, 3 other women and 12 men participated in the 8-h session.
Subjects were at rest during the exposure and were permitted to eat
and drink freely during the experiment with the exception of al-
coholic beverages during the session and the preceding 24 h. None
of the subjects had known occupational or avocational exposure to
methanol, formic acid, or formaldehyde, and none smoked. The
subjects provided written informed consent using forms and pro-
tocols approved by the University of Michigan School of Public
Health and the General Motors Research & Development Center.
Data analysis
Collected data were analyzed as follows. Breath concentrations
were screened by elimination of the few (<1%) observations in
which CO2 levels fell below 3%, indicating nonalveolar air.
Baseline or preexposure concentrations were computed for each
subject by averaging of observations made prior to entry into the
exposure chamber. Descriptive statistics (means, standard devia-
tions, maxima) were computed for each session and across sessions,
the latter by averaging of observations across subjects and sessions
at the same exposure time. Across-session urine data were some-
what more complicated to analyze due to the irregular sampling
schedule. Across-session averages were estimated as the average of
void specimens grouped to the nearest hour.
A ®rst-order clearance model was used to ®t observation Ct
(mg/l for blood and urine; ppm for breath) collected at time t (h)
following exposure (Droz and Fiserova-Bergerova 1992):
Ct  Ca expÿkt  Cb; 1
where Ca is an initial (intercept) concentration, k is the rate constant
(h)1), and Cb is the baseline concentration or endogenous level as
determined using preexposure data. To aid interpretation, k is ex-
pressed as a half-life s (h) such that s  0:693=k. Parameters Ca and
s, associated standard errors, and model-®t R2 were estimated for
methanol concentrations in blood, urine, and breath for each short-
term exposure session. To avoid bias of the half-life estimate, pa-
rameters for the urine data were estimated using midinterval voiding
times (Droz and Fiserova-Bergerova 1992). Data that clearly did
not ®t a ®rst-order decay were omitted, e.g., concentrations that
continued to rise immediately after exposure ceased, and consecu-
tive observations clearly rising long after exposure ceased. Data
falling below detection limits were also omitted. First-order models
were not estimated for the 8-h sessions because samples were col-
lected only 15 min following the end of the exposure, an insucient
duration for estimation of model parameters.
Postexposure breath data were also ®tted to a multicompart-




Ca;i expÿkit  Cb; 2
where Ca;i and ki represent the intercept (ppm) and rate constant
(h)1), respectively, of the ith ®rst-order process or compartment.
Double- and triple-compartmental models (n  2 and n  3, res-
pectively) were considered. Model parameters were estimated using
a forward-dierence quasi-Newton method. Although such models
have been used to represent breath concentrations and mass
balances for four compartments, i.e., blood, vessel-rich tissues,
vessel-poor tissues, and fat (Wallace and Pellizzari 1995), the
compartments may not relate to speci®c physiological variables. In
the present case this approach is primarily used to determine times
when breath sampling will re¯ect concentrations in blood. If the
processes in Eq. 2 are independent, then the total methanol released
from the ith compartment is the integral of (2) from t  0 to t  1
or Ca;i=ki and the fraction of the total methanol released in breath







These fractions apportion the contribution of each compartment.
Concentrations in blood were used to estimate the accumulated
dose and uptake rates. Another solution of the ®rst-order model
was used to estimate the methanol uptake rate in blood occurring
during the exposure Qe (mg/h):
C0  Qe=Vk1ÿ expÿkte  Cb; 4
where C0 is the concentration in blood reached immediately after
departure from the exposure chamber, V is the volume of body
¯uids (42 l for the subjects in the study), k is the rate constant
previously determined for blood, and te is the duration of the ex-
posure (h). This approach assumes ®rst-order clearance, a constant
uptake rate during the exposure, and rapid and uniform parti-
tioning of methanol between blood and other body ¯uids. Because
blood concentrations continued to increase for 15 or 30 min after
exposure had ceased, possibly from desorption of methanol from
the mucous membrane into the airways or due to redistribution in
body compartments, a post-exposure uptake rate term Qpe1 (mg/h)
was estimated by combination of Eqs. 1 and 4:
C15  C0 expÿkDt  Qpe1=Vk1ÿ expÿ0:25 k  Cb; 5
where C15 is the concentration observed at 15-min (0.25 h) after the
exposure had terminated. The postexposure uptake rate Qpe1 is
assumed to be constant during the short (15-min) period consid-
ered: thus, Qpe1 approximates the average uptake over the 15-min
period. Note that Qpe1 may be much smaller than Qe, the uptake
rate during the exposure, and Qpe1 may decline rapidly over the
short period considered. A similar postexposure uptake rate, Qpe2,
was estimated for the 15- to 30-min period. No uptake was found at
postexposure times beyond 30 min. The total uptake of methanol
absorbed over the session, Mtotal (mg), was estimated as:
Mtotal  Qete  0:25Qpe1  0:25Qpe2; 6
where te is the exposure duration (h). Uptake rates were estimated
for the 0.5-, 1-, and 2-h periods of exposure where frequent blood
sampling was available.
Results
Table 1 summarizes results obtained in blood, urine,
and breath samples at each exposure duration and lists
the baseline or preexposure concentrations, maximal
concentrations above baseline, and concentrations
above baseline obtained at 15 min following exposure
for blood and breath (as urine voids were spontaneous,
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this result was not obtained). These concentrations are
averaged across subjects and replicates. The sample size
for the control (no exposure) used 12 exposure sessions,
4 of which involved the core subjects; the 0.5- to 2-h
exposures used the 4 core subjects with 2±3 replicates
each; and the 8-h exposures used 15 sessions (involving
noncore subjects). No systematic bias was noted be-
tween core and noncore subjects. Table 1 also shows the
half-life and intercept statistics from ®rst-order models,
discussed below.
Blood data
Baseline or endogenous concentrations of methanol in
blood averaged 1.8  0.7 mg/l and showed no trend by
subject or exposure duration. Subjects with elevated
baseline levels often maintained a dierential over the
session, e.g., the single highest baseline measurement
(3.4 mg/l) recorded for one subject was similar 8 h later,
well after most methanol from the inhalation exposure
would have cleared. Baseline concentrations were small
in comparison with levels found for 1-h or longer peri-
ods of exposure, and also with the 15-mg/l BEI reported
for methanol in urine (ACGIH 1991). (Blood:urine
partition coecients are near unity.)
Figure 1 shows trends observed in methanol con-
centrations in blood for 0.5-, 1- and 2-h exposure ses-
sions. Means across the eight or nine sessions, corrected
(by subtraction) for preexposure methanol levels, are
plotted. Parameters of the ®rst-order model (Eq. 1) for
Table 1 Mean values and standard deviations recorded for me-
thanol concentrations in blood, urine, and breath and model re-
sults. Maximal and model-intercept concentrations (from a one-
compartment model, Eq. 1) are above baseline concentrations
Control results are based on core subjects and 8 sessions with











Control 1.9 0:9 1.6 0:7 0.1 0:2
30 min 2.0 0:9 1.1 0:5 0.3 0:6
1 h 1.3 0:6 1.5 1:2 0.5 0:8
2 h 1.8 0:7 1.2 0:6 0.5 0:5
8 h 1.8 0:9 2.0 1:7 0.6 0:9
Mean 1.8 0:7 1.3 0:8 0.4 0:6
Maximal concentration:
Control 0.6 0:5 0.2 0:6 0.5 1:2
30 min 5.3 1:4 3.2 1:2 187.0 25:8
1 h 6.6 1:2 4.0 1:4 140.2 31:3
2 h 14.0 1:5 11.0 3:2 152.1 18:5
8 h 30.7 6:9 74.0 33:5 181.4 31:4
Concentration 15 min after exposure:
30 min 4.7 1:9 ± ± 4.0 0:8
1 h 6.1 1:5 ± ± 4.8 1:2
2 h 13.4 1:8 ± ± 7.1 2:4
8 h ± ± ± ± 7.6 1:7
Model-intercept concentration:
30 min 6.0 2:1 5.8 2:4 5.1 3:8
1 h 7.1 1:6 6.4 2:8 4.3 1:3
2 h 14.6 2:9 13.0 2:8 6.1 1:3
Half-life (h):
30 min 1.24 0:25 1.90 0:87 1.51 1:42
1 h 1.41 0:27 1.36 0:78 1.28 0:74
2 h 1.63 0:36 1.39 0:37 1.37 0:31
Mean 1.44 0:33 1.55 0:67 1.38 0.86
Fig. 1 Concentrations of methanol measured in blood following
inhalation of 800 ppm methanol vapor for 30 min, 1 h, and 2 h.
Points represent values, lines show best-®t ®rst-order models
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methanol in blood are listed in Table 1 and predictions
are plotted in Fig. 1. Samples collected at postexposure
times of 0 and 15 min were not used to ®t these models
due to the lag in the maximal concentrations, clearly
seen in the 30-min duration exposure and, to a lesser
extent, in the session data recorded for longer exposures.
In the 30-min exposures, a delay in maxima was seen in
six of eight sessions. With the exception of the samples
collected at postexposure times of 0, 15, or 30 min, the
®rst-order models provided an excellent ®t. Across all
exposure durations and sessions the half-life averaged
1.44  0.33 h and the R2 exceeded 0.95. Models for
individual sessions showed good ®ts (R2  0:92; mean
R2  0:98) and no signi®cant dierence between subjects
or exposure times, although results noted for individual
sessions and subjects could be variable, e.g., one subject
had half-lives ranging from 1.01 to 2.38 h. This vari-
ability can occur due to subject variability, endogenous
methanol production, and experimental errors, includ-
ing baseline estimates. Relative measurement errors in-
creased at the low methanol concentrations that resulted
from short-duration exposures when uptake was small
and at long postexposure times after substantial clear-
ance. As discussed above, half-life estimates excluded
some data, primarily initial points if maxima were not
reached and tailing points if increases were detected.
Although data omissions aected some session results,
eects were small on averaged data. Most half-life esti-
mates had low levels of uncertainty, and few data were
excluded.
Table 1 also lists estimates obtained for the maximal
methanol level using the ®rst-order model at t  0, i.e.,
the model intercept Ca, corrected for baseline Cb. In-
tercepts slightly exceeded observed maxima, possibly
representing a departure from the ®rst-order model,
noninstantaneous uptake, or a time lag for the redistri-
bution of methanol.
Levels of methanol in blood predicted using the ®rst-
order model and the estimated 1.44-hr half-life show
that concentrations do not increase linearly with expo-
sure duration but asymptotically approach the steady-
state level reached after many hours of exposure. For
0.5-, 1-, 2-, and 8-h exposure periods, maxima should
reach 21%, 38%, 62%, and 98% of the steady-state
level, respectively. Experimental results show that dou-
bling of the exposure duration from 1 to 2 h approxi-
mately doubled concentrations (from 6.6  1.2 to
14.0  1.5 mg/l), but quadrupling of the duration from
2 to 8 h only doubled methanol concentrations (to
30.7  6.9 mg/l). These results are in general agreement
with predictions.
Urine data
The analysis of the urine data parallels that for the blood
data. The results are summarized in Table 1, and ob-
served mean values and predictions are plotted in Fig. 2.
In contrast to blood data, urine data have greater vari-
ability, in part due to the smaller sample size (n  3±7
samples, including preexposure samples) as compared
with blood data (11 samples) and to the variation in
voiding times following exposure. However, Figs. 1 and
2 illustrate that methanol concentrations in urine and
blood agree at intermediate times following exposure.
Baseline concentrations in urine were generally small,
averaging 1.3  0.8 mg/l. As observed for the blood
data, elevated baselines were often maintained over the
8- to 9-h duration sessions. Maximal concentrations
increased with exposure time, although trends seen for
individual sessions were sometimes inconsistent until the
exposure duration reached 2 h. The average concentra-
tions across individuals and replicates increased mono-
tonically, but some increases were small, e.g., from
3.2  1.2 to only 4.0  1.4 mg/l for 0.5- and 1-h peri-
ods of exposure, respectively. As compared with the 1-hr
exposure, concentrations increased 3-fold for the 2-h
exposure (11.0  3.2 mg/l) and 7-fold for the 8-h ex-
posure (74  33 mg/l). The 8-h exposure yielded uri-
nary concentrations 23% higher than that expected by
scaling of the ACGIH BEI from 15 mg/l for a 200-ppm
8-h exposure to 60 mg/l for a 800-ppm 8-h exposure.
Urinary methanol levels closely ®t ®rst-order models
and most sessions had R2  0:9. Model intercepts for
individual sessions showed moderate variation, a result
of the few data points available and the need for a 2-h
extrapolation in most cases, i.e., spontaneous voids were
generally collected several hours after departure from
the exposure chamber. (No such extrapolation was
needed for blood since samples were collected immedi-
ately upon exit from the chamber.) Model intercepts
exceeded maxima, especially for the 0.5- and 1-h expo-
sures. These predictions represent concentrations in ur-
Fig. 2 Concentrations of methanol measured in urine following
exposure (see legend to Fig. 1)
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ine at the time of the peak methanol concentration in
blood. Since the corresponding void samples were gen-
erally unavailable, predictions cannot be veri®ed. How-
ever, predicted levels (5.8, 6.4, and 13.0 mg/l for 0.5, 1-
and 2-h durations, respectively) closely matched maxima
in blood (5.3, 6.6, and 14.0 mg/l, respectively). At
equilibrium, methanol concentrations in blood and urine
should be similar, although blood concentrations will be
slightly lower due to its higher lipid content.
Half-life estimates based on urine data were compa-
rable with those based on blood samples, though levels
of uncertainty were higher, particularly for the short-
duration exposures, where analytical uncertainties and
errors in baseline estimates may have obscured incre-
ments due to the inhalation exposure.
Breath data
Methanol concentrations in breath are summarized in
Tables 1 and 2 and plotted in Fig. 3. Data collected at 0,
5, and 10 min after exit from the chamber are not
plotted, as they would be o-scale. Baseline levels of
methanol in breath were low (0.4  0.6 ppm).
The highest methanol concentrations were measured
immediately after departure from the exposure chamber.
Mean concentrations ranged from 140 to 187 ppm (109
to 205 ppm for individual sessions), and no relationship
to exposure duration was observed. Concentrations de-
clined rapidly after exit from the chamber (Table 2). As
discussed by Franzblau et al. (1995), Kumagai and
Matsunaga (1995), and other investigators, concentra-
tions of water-soluble compounds such as methanol in
breath samples can re¯ect concentrations in the liquid
®lm surrounding the mucous membranes rather than
alveolar air. Because these breath concentrations did not
vary with exposure time, the mucous membrane, or at
least its outer ®lm in contact with the chamber air, was
apparently ``saturated'' with methanol at all tested ex-
posure durations. Concentrations in breath recorded
immediately after exposure (averaging 160  30 ppm)
were well below the chamber concentration (800 ppm).
At 15 min after exposure, concentrations in breath were
much lower as the mucous membranes had apparently
desorbed the ``excess'' methanol. Breath concentrations
noted at a postexposure time of 15 min showed mono-
tonic increases with exposure duration, though the in-
crease observed from 30-min to 1-h exposures was small
(from 4.0  0.8 to 4.8  1.2 ppm), as was the increase
Fig. 3 Concentrations of methanol measured in breath following
exposures. Only data recorded at 15min after exposure are plotted
and modeled (see legend to Fig. 1)
Table 2 Statistics of methanol concentrations in blood and breath and the breath predictions based upon equilibrium partitioning with
blood and the indicated partition coecients (NA No blood measurement taken)
Exposure
duration
Sampling time after exposure
0 min 5 min 10 min 15 min 30 min 1 h 2 h 3 h 4 h
Observed concentration in blood (mg/l):
30 min 4.6 NA NA 4.7 4.9 3.5 2.2 1.0 0.5
1 h 6.5 NA NA 6.2 5.4 4.3 2.8 1.5 0.9
2 h 13.4 NA NA 12.0 9.6 6.4 4.1 2.6 1.8
Observed concentration in breath (ppm):
30 min 187.0 15.9 8.0 4.0 2.3 1.3 0.6 0.5 0.0
1 h 140.2 14.7 6.3 4.5 2.7 1.5 0.6 0.6 0.2
2 h 152.1 22.0 11.1 7.1 4.5 3.4 2.1 1.6 1.0
Predicted concentration in breath (ppm) using partition coefficient  2874:
30 min 1.2 NA NA 1.2 1.3 0.9 0.6 0.3 0.1
1 h 1.7 NA NA 1.6 1.4 1.1 0.7 0.4 0.2
2 h 3.5 NA NA 3.2 2.5 1.7 1.1 0.7 0.5
Predicted concentration in breath (ppm) using partition coefficient  1517:
30 min 2.3 NA NA 2.3 2.4 1.7 1.1 0.5 0.2
1 h 3.3 NA NA 3.1 2.7 2.2 1.4 0.7 0.5
2 h 6.7 NA NA 6.0 4.8 3.2 2.1 1.3 0.9
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seen from 2- to 8-h exposures from (7.1  2.4 to
7.6  1.7 ppm). In contrast, methanol in blood doubled
in the 1- to 2-h exposures and also in the 2- to 8-h ex-
posures. The similar concentrations observed in breath
suggest that desorption from the mucous membranes
was incomplete at a postexposure time of 15 min. The
multicompartmental models, discussed below, con®rm
these trends.
First-order models were estimated using breath
samples collected at 15 min to 6 h after departure from
the exposure chamber (Fig. 3). Model ®ts were high
(0:89  R2  0:96). The mean estimated half-life
(1.38  0.86 h) was slightly shorter than that found
using blood or urine data. On omission of the data from
e.g., 0±30 min, 0±1 h, and 0±2 h, half-life estimates
considerably lengthened, apparently a result of exclusion
of the desorption processes. Again, the multicompart-
mental models provide a way to address these changes
(artifacts) in the half-life estimated from breath data.
Comparison of blood and breath data
Table 2 lists the average concentrations of methanol
observed in blood and breath and those predicted in
breath using two blood:air partition coecients: 2874
(Pezzagno et al. 1983) and 1518 (Fiserova-Bergerova
and Diaz 1986). For postexposure times of less than
1 h, observed concentrations in breath exceeded pre-
dictions, indicating that concentrations detected in
breath were not in equilibrium with those found in
blood. Dierences were small at post-exposure times of
0.5±1 h. In contrast to previous work, where the larger
partition coecient was found to provide a good ®t to
breath samples in subjects with dermal exposure
(Franzblau et al. 1995), the smaller coecient appears
more accurate. The next section con®rms that 0.5 h is
needed for full desorption of methanol from the upper
respiratory tract.
Multicompartmental models for breath data
Parameters of three-compartment models calibrated for
the breath data are shown in Table 3. Two-compart-
ment models poorly ®t the 5- and 10-min postexposure
observations. Three-compartment models provided an
excellent ®t (R2  0:99 and low relative errors). The ®rst
compartment has a short half-life (0.25±1.2 min), a high
initial concentration (103±151 ppm), and accounts for
4±39% of the exhaled methanol. The second compart-
ment has an intermediate half-life (3.7±7.5 min) and a
moderate initial concentration (8.2±44 ppm). These
compartments may re¯ect fast and slow desorption
processes from the mucous membranes. The third
compartment had the slowest release rate (half-life 0.99±
1.74 h) and a low initial concentration (2±5.1 ppm),
slightly below the concentrations measured at 15 min
Table 3 Parameters of the three multicompartmental models (Eq.
2), ®tted to postexposure breath data for exposure durations of 0.5,
1, and 2 h. Mean values SD are listed for three exposure dura-
tions (Fraction Percentage of the estimated total absorbed dose by
indicated compartment)
Exposure duration
30 min 1h 2 h Mean SD
Compartment 1 Half-life (min) 0.52 1.17 0.25 0.64 0:47
Intercept (ppm) 151.0 129.0 103.4 127.8 23:8
Fraction (%) 20.2 38.5 3.6 20.8 17:5
Compartment 2 Half-life (min) 3.83 7.46 3.69 5.00 2:14
Intercept (ppm) 34.0 8.2 43.6 28.6 18:3
Fraction (%) 33.7 15.6 22.5 24.0 9:1
Compartment 3 Half-life (hr) 1.48 0.99 1.74 1.40 0:38
Intercept (ppm) 2.0 3.0 5.1 3.4 1:5
Fraction (%) 46.0 45.9 73.9 55.3 16:1
Table 4 Estimated contribution
of desorption processes to
breath concentration at the
indicated postexposure times
and exposure durations as
based on multicompartmental
models and assuming 800 ppm
exposure; 8-h results use the 2-h
model except for the intercept
of the third compartment,
which is scaled from blood data
to 11.2 mg/l
Postexposure Desorption contribution (%) for exposure duration
time (min) 30 min 1 h 2 h 8 h
0 98.9 97.8 96.7 92.9
5 87.8 80.6 77.7 61.2
10 75.0 57.1 58.5 38.9
15 55.8 44.7 36.3 20.5
20 34.7 34.8 18.7 9.4
25 18.3 26.3 8.5 4.0
30 8.6 19.2 3.6 1.7
35 3.8 13.6 1.5 0.7
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after exposure or estimated as the model intercept (Ta-
ble 4). The half-life for this compartment averaged
1.40  0.38 h, similar to that estimated using blood or
urine. The third compartment re¯ects end-expired or
alveolar air, which should be in equilibrium with blood.
Although the short-term compartments contributed a
minor fraction of the total methanol exhaled, particu-
larly at longer exposure durations, concentrations due to
the short-term compartments were much higher, albeit
brie¯y, than levels in alveolar air.
Table 4 shows the combined contribution of the two
short-term compartments to the total breath concen-
tration (resulting from all three compartments). For
example, short-term processes account for 56% of the
methanol in a breath sample taken at 15 min after a 30-
min, 800-ppm exposure, meaning that breath sampling
will overestimate concentrations in blood by a factor of
2. As blood concentrations increase with longer expo-
sure times, these contributions will decrease. For 1- and
2-h exposures, short-term processes contribute 45%
and 36%, respectively, of methanol concentrations at
15 min. Eects on 8-h exposures are estimated in Ta-
ble 4 using parameters of the 2-h model, except that the
intercept of the third compartment is set to 11.2 mg/l,
scaled from the 2-h data using 2- and 8-h concentrations
in blood. For an 8-h exposure, short-term processes
account for 21% of methanol at 15 min. Additional time
reduces the contributions of the short-term processes.
Assuming that 5% contributions are acceptable,
30 min in a methanol-free environment is required,
and somewhat less time is needed for longer periods of
exposure.
Methanol uptake rates and doses
Table 5 lists the uptake rates and doses estimated using
the blood data and Eqs. 4±6. The uptake rate Qe found
for the short-term exposures, 346 to 448 mg/h, was
substantially below the 587-mg/h rate noted for the 8-h
exposures. Uptake into blood continued for 15 min after
the termination of exposure, with the average rate being
131  76 mg/h. Some uptake appeared to continue in
the 15- to 30-min postexposure period, but results were
inconsistent. The contribution of postexposure uptake is
indicated in the lower portion of Table 5. Post-exposure
uptake accounts for 10% of the total uptake in the 30-
min exposures and for 5±6% in the 1- and 2-h exposures.
The higher uptake rates recorded for the 8-h expo-
sures may be attributable to dierences in the study
population. The 8-h exposures used a group that was
younger (38  14 versus 54  4 years), taller (177  8
versus 166  1 cm), slightly heavier (79  18 versus
78  13 kg), more numerous (15 versus 4 subjects), and
predominantly male (80% men versus 100% women). In
addition, the clearance of methanol may have been
slower in the 8-h exposure group due to (partial) meta-
bolic saturation. If so, the use of the 1.44-h half-life,
which would be incorrect at that exposure level, would
increase the apparent uptake rate. Thus, although sub-
jects in the 0.5- to 2-h exposures were identical and their
results are comparable, they should not be compared
with the uptake rates noted for the 8-h exposure group.
Discussion
Interpretation of breath samples
Although it is the easiest of the three BEIs to sample and
analyze, the interpretation of breath samples is compli-
cated by the uptake and release of methanol in the moist
surfaces and, possibly, deeper layers within the head
airways and tracheobronchial regions. Many anatomi-
cal, physiological, and chemical factors can in¯uence the
uptake and retention of water-soluble vapors, including
mouth versus nose breathing, solubility and diusion
rates of the vapor, airway dimensions, and respiratory
characteristics, e.g., ¯ow rate. Most surfaces in the head
airways and tracheobronchial regions are covered by a
thin mucous layer. The respiratory bronchioles, far
down in the respiratory tract just above the alveolar
Table 5 Methanol uptake rates and total methanol uptake esti-
mated using blood data and ®rst-order models (Qe denotes uptake
during the exposure period, Qpe1 and Qpe2 apparent uptake into







Qpe1 (0±15 min) Qpe2 (15±30 min)
Uptake rates (mg/h):
30 min 432 109 161 NA
1 h 346 69 )14 NA
2 h 448 215 31 NA
8 h 630 NA NA NA
Average 464 119 131 76 59 91 NA
Uptake (mg):
30 min 216 (76%) 27 (10%) 40 (14%) 284
1 h 346 (96%) 17 (5%) )4 ()1%) 359
2 h 897 (94%) 54 (6%) 8 (1%) 958
8 h 5036 (99%) 33 (1%) 15 (0) 5084
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ducts and tracts, contribute by far the greatest surface
area of mucus lined surfaces, 7.5 m2 as compared with
0.047 m2 in the head airways region (including the lar-
ynx and esophagus), 0.03 m2 in the trachea and bronchi,
and 0.26 m2 in the bronchioles (ICRP 1994). Walls of
the respiratory bronchioles consist of a 5- to 10-lm-
thick mucous membrane (Johanson 1991), a single-layer
respiratory epithelium of cuboidal cells, and smooth-
muscle layers. The much larger 140-m2 area of the al-
veolar ducts and sacs consists of squamous alveolar cells
without a mucous layer.
The multicompartmental model, an empirical ap-
proach to deal with a complex physiological process,
suggests fast and slow release processes for the head
airways and tracheobronchial regions. The mucous
membranes are not homogeneous, however, and
``desorption'' may also re¯ect diusion through a liquid
®lm covering the mucous membrane or through cells, a
process that is not expected to be of the ®rst order. The
fastest compartment (half-life 0.64  0.47 min) may
re¯ect the outermost layers of the mucous membrane
that achieves near-instantaneous equilibrium with air.
The second compartment (half-life 5.0  2.1 min) may
re¯ect deeper layers of the respiratory system in¯uenced
by nonequilibrium processes such as diusion. To pro-
vide more insight into these compartments we conducted
several simulations using a time-varying diusion model.
Many aspects of the data could be reproduced by
modeling of uptake in a homogeneous sheet representing
the moist surfaces and deeper layers within the head
airways and tracheobronchial regions. Methanol uptake
and release from one side of the sheet in equilibrium
with methanol vapor was modeled. The sheet's opposite
side was impermeable. The observed kinetics could be
approximated using a sheet thickness of 0.12 cm (a ®tted
parameter), a diusion coecient of 10)5 cm2/s (an ap-
proximate value for methanol in mucus or water), and
an arbitrary concentration-area product scaled to match
the data (a second ®tted parameter). The sheet thickness
and diusion coecient determines the dynamics. Al-
though the concentration-area product could not be
justi®ed, the thickness implies penetration of methanol
well beyond the 10-lm ®lm that coats the airways.
While simplistic, the model suggests that the physical
dimension of the process is larger than the very thin
mucous membrane ®lm. However, lags in desorption
processes also could result from poorly ventilated
``dead'' spaces or for other reasons.
Estimates of postexposure uptake (Table 5) from the
desorption of solvent from the mucous membranes or
some other reservoir are preliminary. The time resolu-
tion of blood sampling (15 min) imperfectly captures the
fast desorption kinetics (half-lives 0.6 and 5 min), and
the small sample size and experimental errors contribute
additional uncertainties. Nonetheless, a delay in maxima
was seen in most of the 30-min exposure sessions. Ad-
ditional evidence that mucous membranes represent a
reservoir is shown by breath concentrations of 100±
200 ppm measured upon exit from the exposure cham-
ber and by concentrations that remained elevated for
15±30 min. For the shortest exposures tested this reser-
voir probably contributed no more than 10% of the
total uptake. For exposures exceeding 1±2 h, its eect
appears negligible. This reservoir may be important for
brief exposure to water-soluble vapors, where it in-
creases uptake.
Several physiologically based models take into ac-
count the absorption of solvents in the mucous mem-
brane of the respiratory tract, including nasal uptake of
solvents (Gerde and Dahl et al. 1991; Morris et al. 1993),
uptake of solvents in the wall of the respiratory tract
(Johanson 1991), and the kinetics of the mucous layer
(Kumagai and Matsunaga 1995). Kumagia and Matsu-
naga (1995) considered only the outermost layer (1±
5 lm thick) of the mucous membrane and a 0.5-m2
region above the terminal bronchioles, giving a mucous
volume of 0.5±2.5 cm3. This layer was assumed to act as
a single compartment in equilibrium with vapor con-
centrations and, thus, had a very fast time constant.
Although other models that do not incorporate a mu-
cous membrane reservoir have successfully simulated
inhalation exposure to methanol (e.g., Horton et al.
1992), these models were not utilized for short-term
exposure, nor were suciently frequent blood measure-
ments taken to observe the reservoir eect. Additional
work is needed to con®rm the reservoir eect, possibly
using yet shorter periods of exposure and more frequent
blood sampling.
It is clear that exposure and half-life estimates of wa-
ter-soluble compounds should not be based on breath
samples collected soon after a potential inhalation expo-
sure. The equilibrium and multicompartmental models
indicate that short-term processes, e.g., desorption, can
dominate concentrations measured in breath. For meth-
anol, at least 30 min is needed for breath samples to re¯ect
alveolar air that is largely (95%) free of solvent ab-
sorbed elsewhere in the respiratory system. This is longer
than the 15 min we previously estimated (Franzblau et al.
1995) using 8-h exposure sessions. The short periods of
exposure used in the present study provided better op-
portunities to evaluate breath monitoring as a BEI.
Lung retention
Sedivec et al. (1981) and other investigators calculate the
lung retention by the dierence in concentrations mea-
sured between inspired and expired air divided by the
concentration detected in inspired air. Using averages, a
79% lung retention factor is calculated from the re-
ported data as compared with the 58% value found by
Sedivec et al. (1981) and the 65±74% value found by our
co-workers (Lee et al. 1992). Sedivec et al.'s results dier
because we employed a breath-sampling maneuver de-
signed to expel air from deep within the lungs, and the
sampling apparatus excluded the ®rst 0.5 l of breath
exhaled. Both steps were designed to exclude air from
the tracheobronchial ``dead space,'' where methanol
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concentrations may approach the chamber concentra-
tion, and to sample alveolar air, where concentrations
should be much lower and re¯ect equilibrium with levels
in blood.
Clearance
Methanol is excreted unchanged in urine and exhaled
breath and is metabolized primarily in the liver. Because
methanol's toxic acute properties are linked to inter-
mediate metabolites, not the alcohol itself, the kinetics
of the metabolic process are important (Kavet and
Nauss 1990). Faster clearance of methanol would imply
more rapid and severe formate generation and acidosis,
as well as potentially greater acute toxicity. Several
studies in humans have examined clearance (see the re-
view of Kavet and Nauss 1990). Using oral exposure in
three volunteers and urine sampling, Leaf and Zatman
(1952) estimated that methanol disappearance followed
®rst-order kinetics with a half-life of 3 h. Using 8-h
inhalation exposure, four volunteers, and urine sam-
pling, Sedivec et al. (1981) estimated a half-life of 1.5±
2 hr. Examining end-shift urine samples on occupational
inhalation exposure and also earlier dermal exposure
studies, Kawai et al. (1991) estimated a half-life of 7±8 h.
The half-life estimates reported herein, i.e.,
1.44  0.33 h in blood, 1.55  0.67 h in urine, and
1.40  0.38 h in breath (from the multicompartmental
model) are consistent with those found by Sedivec et al.
(1981). Leaf and Zatman's (1952) work may not be
representative since oral exposure may involve a reser-
voir eect in the gastro-intestinal tract that increases the
apparent half-life, and their results are based on only
two subjects. Kawai et al.'s (1991) estimate is based on
®eld conditions without controls on exposures, and it
has the possibility of interferences. Laboratory studies
should be free of these concerns. Dermal exposures also
involve additional reservoirs and buers that can bias
half-life estimates (Batterman and Franzblau 1997).
Note that the clearance of methanol can be much slower
following high doses, i.e., the methanol half-life is 1
day for doses exceeding 1 g/kg (Kavet and Nauss 1990),
and non-®rst-order kinetics (e.g., using the Michaelis-
Menton equation) may be needed to describe elimina-
tion (Droz and Fiserova-Bergerova 1992; Perkins et al.
1995). Such doses far exceed those used in the present
study.
Half-life estimates based on blood, urine, and breath
samples were comparable. Blood data had lower levels
of uncertainty and may be somewhat more accurate
since the time of collection can be accurately determined.
In contrast, the urine samples represent time-weighted
averages that require correction to the midinterval
voiding time. Thus, postexposure or end-shift urine
sampling seems unlikely to accurately re¯ect transient
exposure. Breath samples are more dicult to interpret.
Because desorption processes tend to cause very high
initial concentrations, estimates of clearance or dose
from breath samples must either use multicompart-
mental models or exclude data potentially aected, e.g.,
the ®rst 30 min following an air exposure.
Evaluation of biological monitoring
for short-term exposures
The ability to quantify short-term inhalation exposure
can be a rigorous test of a biological measurement, and
the results of this study demonstrate several strengths
and weaknesses of urine, blood, and breath measure-
ments. In the 2-h 800-ppm exposure, which is equivalent
to the concentration-time product of the TLV-TWA, the
concentration of methanol in urine averaged 11 mg/l,
below the BEI (15 mg/l), and the peak lagged the ter-
mination of exposure by several hours. Soon after the
exposure, blood concentrations averaged 14 mg/l, close
to the BEI. In practice, it is dicult to collect blood
samples, especially after a short-duration exposure.
Furthermore, the relationship between the exposure
period and the concentration of biological samples is not
expected to be linear unless clearance is slow relative to
the exposure duration. If the partition coecient is
known, then doses can be derived from breath samples;
however, breath sampling must occur at least 30 min
after inhalation to allow sucient desorption of solvent
from the mucous membranes.
Measurements in breath, urine, and blood taken
during and after short-term inhalation exposure can be
used to estimate the dose received by an individual,
given that the elapsed time since the exposure and ®rst-
order corrections are made using appropriate methods.
However, signi®cant errors may result in quanti®cation
of the dose if exposures are transient and their timing
is unknown. Nonetheless, because they incorporate the
eects of physiological factors that aect the uptake
and clearance of toxicants among individuals as well as
the dermal exposure pathway, biological measurements
oer advantages in comparison with area and envi-
ronmental monitoring. The limitations of biological
monitoring must also be viewed with respect to the
feasibility and cost of monitoring of breathing-zone
air.
In conclusion the experimental results showed con-
sistent patterns with regard to the methanol concentra-
tions detected in breath, urine, and blood following
short-term inhalation exposure. As expected, concen-
trations did not increase linearly with exposure duration
due to the fairly rapid clearance of methanol. Clearance
half-lives estimated using blood, breath, and urine data
were consistent, and the best estimate (1.44  0.33 h) is
a meaningful change from the 3-h half-life often cited
(e.g., Kavet and Nauss 1990). Lags in blood concen-
tration with increasing exposure time provide support
for a small reservoir or buer for methanol, most likely
in the mucous membranes of the respiratory tree. The
same reservoir greatly increases breath concentrations
for up to 30 min following exposure. Concentrations in
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blood and urine lag the exposure, and concentrations in
urine do not reach levels expected, given the ACGIH-
recommended BEI. Although the interpretation of bio-
logical samples for short-term exposure is more complex
than that for exposure that is relatively constant over a
shift, simple ®rst-order models can be used to account
for clearance during and following exposure.
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